We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Delaware

Delaware Law360 provides breaking news and analysis on legal and regulatory issues in Delaware. Coverage includes high-stakes litigation, policy developments, and corporate deals affecting the state.



Sign up for a 7-day FREE trial today!



Latest News in Delaware

  • July 20, 2018

    Oaktree To Counter Top Bidder In Claire’s Del. Ch. 11

    Private equity firm Oaktree Capital Management LP reported Friday it intends to top the current best offer for bankrupt Claire’s Inc., potentially disrupting what until now has been a pre-arranged but hotly contested plan to hand the retail jewelry and accessories chain to its first-lien lenders.

  • July 20, 2018

    Weinstein Judge Lets 'Children Of The Corn' Suit Go Ahead

    A Delaware bankruptcy judge on Thursday lifted a Chapter 11 stay clearing the way for a movie producer to resume his lawsuit in California federal court against The Weinstein Co. disputing sequel, remake and spinoff rights to the 1984 horror film “Children of the Corn.”

  • July 20, 2018

    Gibson Brands Lender Wants Better Ch. 11 Sale Effort

    A major creditor to bankrupt guitar maker Gibson Brands Inc. objected Friday to the company’s disclosure statement and vote solicitation plan in its Delaware Chapter 11 case, arguing the company had failed to market the business properly and offering to help fund a market check.

  • July 20, 2018

    Chancery Court Tosses Investor Challenge To Energy Co. Deal

    A Delaware Chancery Court judge on Friday rejected a challenge by a shareholder in Earthstone Energy Inc. to the company’s acquisition of Bold Energy III LLC, saying the shareholder failed to show private equity firm EnCap Investments LP forced the company into a raw deal.

  • July 20, 2018

    Full Fed. Circ. Should Nix UCB's Vimpat Patent, Accord Says

    Generic-drug makers Accord Healthcare Inc. and Intas Pharmaceuticals Ltd. on Thursday urged the full Federal Circuit to consider invalidating a UCB Inc. patent covering the epilepsy drug Vimpat, arguing that the court's panel relied on subjective criteria to uphold the patent instead of legally mandated objectivity.

See more Delaware news

Delaware

Areas of Coverage

  • LITIGATION
  • Court of Chancery cases
  • Antitrust litigation
  • Class actions
  • Environmental suits
  • Labor and employment issues
  • Intellectual property cases
  • Product liability and consumer protection disputes
  • Securities disputes
  • Bankruptcy proceedings
  • AGENCIES
  • Federal Trade Commission
  • U.S. Consumer Product Safety Commission
  • U.S. Department of Justice
  • U.S. Department of Labor
  • U.S. Environmental Protection Agency
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. Securities and Exchange Commission
  • Delaware Attorney General’s Office
  • ENFORCEMENT
  • Investigations and enforcement actions by state and federal prosecutors
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures involving companies headquartered in Delaware
  • Real estate deals
  • PROFILES
  • Nominations, appointments, and elections of judges and agency officials in Delaware
  • Personnel moves
  • Profiles of Delaware judges, litigators, and firms

Readership

  • Lawyers at top law firms practicing in Delaware
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys working with Delaware-based companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals